|
|
9700 Great Seneca Highway Rockville, MD 20850 USA phone:301 762 9066 fax:
|
|
| Symbol |
|
| Exchange |
|
| Founded |
0 |
| Employees |
|
|
|
| www.seegene.com
|
|
|
|
 |
| Summary Description |
|
 |
| Management |
|
| |
|
|
|
|
|
| Keywords |
| PCR, viral detection, j2008 |
|
|
|
| Description |
|
Founded in 2000, Seegene, Inc, has brought a new dimension to PCR which is the core tool in microbiology. We have developed the innovative technologies, ACP (Annealing Control Primer)TM and DPO (Dual Specific Oligonucleotide)TM which maximize the sensitivity and specificity of PCR. These breakthrough technologies have been applied in various fields of genomic research and yielded significant achievements. |
 |
| Products / Services |
Seeplex? is a breakthrough multiplexing PCR technology that enables a new standard
in simultaneous multi-pathogen detection. Seegene applies its novel and proprietary
Seeplex? system utilizing "DPO" (Dual Priming Oligo)" to create multi-pathogen tests
delivering maximum specificity, reproducibility and sensitivity. Seeplex can be applied
to broad range of molecular diagnostics area including human, animal, plant, and
microorganism.
|
 |
| Technology / Differentiation |
| Seegene specializes in oligo technologies and has two core oligo platform named "ACP" (Annealing Control Primer) and "DPO" (Dual Priming Oligonucleotide). The technologies are covered by an extended portfolio of international patents. Many of them are available for OEM & licensing. The internal developments are the technological basis for Seegene's growing range of innovative products for in vitro diagnostics in the laboratory. |
 |
 |
|
|
|
|
|
|